Immunostaining of purified neutrophils with anti-microtubule-associated protein 1A/1B-light chain 3 (LC3) antibody showed that AD treatment significantly reduced PMA–induced up-regulation of LC3 (Figure 6A,B). The gene discussed is MAP1LC3A; the disease is Alzheimer disease.